Lucid Diagnostics
LUCD · NASDAQ
$0.3519−$0.0255 (−6.76%)TodayMarket closed ·
Prev close $0.3774
Who owns LUCD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 44.8% of LUCD’s shares.
- PAVmed Inc20.3%
- Alyeska Investment Group, L.P.4.6%
- BlackRock Institutional Trust Company, N.A.4.0%
- Vanguard Capital Management, LLC3.4%
- Next 6 largest institutions12.4%
- All other shareholders55.2%
| Holder | Shares | % of shares |
|---|---|---|
| PAVmed Inc | 38.82M | 20.35% |
| Alyeska Investment Group, L.P. | 8.86M | 4.64% |
| BlackRock Institutional Trust Company, N.A. | 7.59M | 3.98% |
| Vanguard Capital Management, LLC | 6.56M | 3.44% |
| Two Seas Capital LP | 6.00M | 3.15% |
| Masters Capital Management, L.L.C. | 4.00M | 2.10% |
| abrdn Inc. | 3.82M | 2.00% |
| Geode Capital Management, L.L.C. | 3.79M | 1.99% |
| Aklog (Lishan) | 3.64M | 1.91% |
| State Street Investment Management (US) | 2.44M | 1.28% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 4.55M | 2.38% |
| abrdn Healthcare Opportunities Fund | 3.64M | 1.91% |
| iShares Russell 2000 ETF | 3.55M | 1.86% |
| Vanguard Extended Market Index Fund | 1.86M | 0.98% |
| Fidelity Small Cap Index Fund | 1.58M | 0.83% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $245.27K (1 trade) of LUCD on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Matheis Dennis | Buy | 245.00K | $245.27K |
Short interest
Settled Sep 30, 2026
- Shares short
- 13.46M
- Days to cover
- 10.32
- % of shares outstanding
- 7.05%
- Average daily volume
- 1.30M
- Change since last report
- +4.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.